Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Indaptus Q2 Net Loss Narrows to $1.8 Million

None

Indaptus Therapeutics (INDP) reported a net loss of $1.8 million, or $0.02 per basic and diluted share, for the second quarter ended June 30, 2026, compared with a $5.2 million loss in the prior-year period.

The company completed a $12.0 million private placement in June and reported $11.6 million in cash, cash equivalents and short-term investments at quarter-end. Indaptus said it has no active clinical development programs and is evaluating strategic alternatives for Decoy20 and its broader operations.

  • Research and development expense fell 83% year over year to $0.4 million.
  • General and administrative expense declined 37% to $1.4 million.
  • Six-month net loss was $4.3 million, compared with $9.8 million a year earlier.
  • The June 17 private placement sold 20.0 million common shares at $0.60 per share.
  • Cash and cash equivalents totaled $7.6 million, with $4.0 million in short-term investments, as of June 30.
EARLY ACCESS
Receive INDP Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$INDP Hedge Fund Activity

We have seen 4 institutional investors add shares of $INDP stock to their portfolio, and 3 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • CITADEL ADVISORS LLC added 39,018 shares (+inf%) to their portfolio in Q1 2026, for an estimated $71,012
  • GEODE CAPITAL MANAGEMENT, LLC added 29,463 shares (+109.1%) to their portfolio in Q2 2026, for an estimated $88,389
  • UBS GROUP AG removed 29,002 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $52,783
  • MORGAN STANLEY added 2,697 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,908
  • TOWER RESEARCH CAPITAL LLC (TRC) removed 1,890 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $5,670
  • BANK OF AMERICA CORP /DE/ removed 25 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $45
  • CWM, LLC added 2 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles